「瑞德西弗可讓插管者致死率降到18%」Two thirds of COVID-19 patients improve after Gilead drug. France Reports Heart Incidents Linked to Drug Promoted by Trump. Potential Coronavirus Drugs May Cost as Little as $1, Study Says

"Gilead藥物治療後三分之二的COVID-19患者有所改善。

法國報導了與特朗普提倡的藥有關的心臟病事件。

研究稱，潛在的冠狀病毒解藥價格可能低至1美元

8. 《新英格蘭醫學期刊》最新文章說，「瑞德西弗可讓插管者致死率降到18%」，這是相當顯著的成效，須知原本致死率至少50-60%，而張上淳也說台灣試驗成果不錯，實在令人振奮。他也說味嗅覺喪失大都在十幾天後可以恢復，不會有後遺症。
***

Potential coronavirus treatments could be made for as little as $1, well below their typical price tags in pharmacies.


BLOOMBERG.COM

Potential Coronavirus Drugs May Cost as Little as $1, Study Says



***


More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc. , according to new data based on patient observation.


REUTERS.COM

Two thirds of COVID-19 patients improve after Gilead drug: NEJM








BLOOMBERG.COM

France Reports Heart Incidents Linked to Drug Promoted by Trump
France reported 43 cases of heart incidents linked to treating coronavirus patients with hydroxychloroquine, the malaria drug President Donald Trump has repeatedly touted as a potential “game changer.”
Bloomberg Asia


There's some trouble with the president's potential "game-changer."